Tag Visualization: Top 50 related tags by occurrence
Wall Street Analysts Think Vir Biotechnology (VIR) Could Surge 188.65%
Added to Collection on: 2024-05-07 16:05:00
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Multiple Abstracts highlighting Vir Biotechnology's Latest Hepatitis Delta and B Data ...
Added to Collection on: 2024-05-23 15:30:25
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Vir Biotechnology (VIR) Up on Positive Data From HDV Study - June 6, 2024 - Zacks.com
Added to Collection on: 2024-06-06 17:32:06
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
FDA fast tracks Vir Biotech's hepatitis delta therapy By Investing.com
Added to Collection on: 2024-06-26 19:41:23
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Vir Biotechnology, Inc. (VIR) Moves to Strong Buy: Rationale Behind the Upgrade
Added to Collection on: 2024-06-28 19:45:13
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Vir Biotechnology Insiders Sold US$1.3m Of Shares Suggesting Hesitancy - Simply Wall St
Added to Collection on: 2024-07-15 16:47:05
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Vir Biotechnology to Report Second Quarter 2024 Financial Results on August 1, 2024
Added to Collection on: 2024-07-19 13:56:37
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by Profund Advisors LLC
Added to Collection on: 2024-09-28 22:53:57
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript - Insider Monkey
Added to Collection on: 2024-11-02 14:33:27
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Critical Contrast: Cardiff Oncology (NASDAQ:CRDF) versus Vir Biotechnology (NASDAQ:VIR)
Added to Collection on: 2025-02-23 06:34:12
Tags for this article:
Click the tags to see associated articles and topics
View Article Details